Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ridley agriproducts pty ltd. - magnesium oxide - oral block, lick - magnesium oxide mineral-magnesium active 150.0 g/kg - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - grass tetany | hypomagnesaemia | staggers

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - selenium as sodium selenate; vitamin b12 = cyanocobalamin; vitamin b12a = hydroxocobalamin - parenteral liquid/solution/suspension - selenium as sodium selenate mineral-selenium active 2.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 0.2 mg/ml; vitamin b12a = hydroxocobalamin vitamin-b12 active 1.72 mg/ml - nutrition & metabolism - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - selenium deficiency | vitamin b12 deficiency | anaemia | cobalt deficiency | white muscle disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - vitamin b12 = cyanocobalamin; vitamin b12a acetate = hydroxocobalamin acetate - parenteral liquid/solution/suspension - vitamin b12 = cyanocobalamin vitamin-b12 active 0.2 mg/ml; vitamin b12a acetate = hydroxocobalamin acetate vitamin-b12 active 1.8 mg/ml - nutrition & metabolism - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - vitamin b12 deficiency | anaemia | cobalt deficiency

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - selenium as sodium selenate; vitamin b12 = cyanocobalamin; vitamin b12a = hydroxocobalamin - parenteral liquid/solution/suspension - selenium as sodium selenate mineral-selenium active 5.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 0.0675 g/ml; vitamin b12a = hydroxocobalamin vitamin-b12 active 0.0675 mg/ml - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - vitamin & mineral deficiency

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproton pty. ltd. - 6-phytase (i.u.b. no. 3.1.3.26); alpha amylase; beta glucanase; cellulase; protease; xylanase - oral powder, pre-mix - 6-phytase (i.u.b. no. 3.1.3.26) enzyme active 600.0 units/gm; alpha amylase enzyme active 400.0 units/gm; beta glucanase enzyme active 700.0 bio bu/g; cellulase enzyme active 6000.0 bio cu/g; protease enzyme active 700.0 units/gm; xylanase enzyme active 10000.0 bio xu/g - nutrition & metabolism - pigs | poultry | boar | breeders | broiler | chickens | chicks | chooks | day old chicks | gilt | hatchlings | layers | piglet | - improve digestibility of cereal feeds

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 180.0 m cfu/g; enterococcus faecium biological-organism active 180.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 180.0 m cfu/g; lactobacillus acidophilus biological-organism active 180.0 m cfu/g; lactobacillus plantarum biological-organism active 180.0 m cfu/g; lactobacillus rhamnosus biological-organism active 180.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 180.0 m cfu/g - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 60.0 m cfu/g; enterococcus faecium biological-organism active 60.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 60.0 m cfu/g; lactobacillus acidophilus biological-organism active 60.0 m cfu/g; lactobacillus plantarum biological-organism active 60.0 m cfu/g; lactobacillus rhamnosus biological-organism active 60.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 60.0 m cfu/g - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 0.0 p; enterococcus faecium biological-organism active 0.0 p; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 0.0 p; lactobacillus acidophilus biological-organism active 0.0 p; lactobacillus plantarum biological-organism active 0.0 p; lactobacillus rhamnosus biological-organism active 0.0 p; streptococcus salivarius subspecies thermophilus biological-organism active 0.0 p - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmametics products a division of max biocare pty ltd - ascorbic acid,calcium folinate,calcium hydrogen phosphate,calcium pantothenate,colecalciferol,cyanocobalamin,d-alpha-tocopherol,dunaliella salina,folic acid,heavy magnesium oxide,iron (ii) glycinate,natural fish oil,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavine,thiamine nitrate,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tigecycline, quantity: 50 mg - injection, powder for - excipient ingredients: arginine; hydrochloric acid; sodium hydroxide - tigecycline juno is indicated for the treatment of the following infections in adults:,? complicated skin and skin structure infections, including those with methicillin resistant staphylococcus aureus (mrsa), where there is suspected or proven resistance to, intolerance of, or there are co- morbidities preventing the use of, other available agents.,? complicated intra-abdominal infections, where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.